Study Details

General Information

Redhill H. pylori RHB-105-01

A Randomized, Placebo-Controlled, Phase III Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobactor pyori (H. Pylori) Infection in Non--Investigated Dyspepsia Patients.

ProtocolRHB-105-01
IdentifierRHB-105-01 Site Number 005
UID39dfe455-9d5b-437b-9c26-55afe782fd2b
StatusDone - Archived
Phase3
CategoryH. pylori / Adult
Launch Year2013
NCT Number-
Created2013-09-10 11:09
Last Updated2013-09-10 11:09

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2015-04-13No
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.2013-11-20No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2015-10-28No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
CoordinatorValenzuela, LouisitoLValenzuelaNo
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorRedhill Biopharma Ltd
DivisionRedhill Biopharma Ltd
TeamRedhill Biopharma Ltd
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref28597/6
CROClinipace, Inc
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?